BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35836806)

  • 21. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
    Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
    Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
    Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.
    Hussain Z; Bertran T; Finetti P; Lohmann E; Mamessier E; Bidaut G; Bertucci F; Rego M; Tomasini R
    Cell Commun Signal; 2024 Jan; 22(1):1. PubMed ID: 38167013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
    Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
    Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
    Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
    Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
    J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Zhang T; Ren Y; Yang P; Wang J; Zhou H
    Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
    Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
    PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
    Zhang L; Yao J; Li W; Zhang C
    Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression.
    Iwamoto C; Ohuchida K; Shinkawa T; Okuda S; Otsubo Y; Okumura T; Sagara A; Koikawa K; Ando Y; Shindo K; Ikenaga N; Nakata K; Moriyama T; Miyasaka Y; Ohtsuka T; Eto M; Akashi K; Nakamura M
    Cancer Lett; 2021 Aug; 512():15-27. PubMed ID: 33961925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 34. ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer.
    Li YX; Zhu XX; Wu X; Li JH; Ni XH; Li SJ; Zhao W; Yin XY
    Cancer Lett; 2022 Sep; 544():215802. PubMed ID: 35732215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer.
    Yousuf S; Qiu M; Voith von Voithenberg L; Hulkkonen J; Macinkovic I; Schulz AR; Hartmann D; Mueller F; Mijatovic M; Ibberson D; AlHalabi KT; Hetzer J; Anders S; Brüne B; Mei HE; Imbusch CD; Brors B; Heikenwälder M; Gaida MM; Büchler MW; Weigert A; Hackert T; Roth S
    Gastroenterology; 2023 Oct; 165(4):891-908.e14. PubMed ID: 37263303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression].
    Kuznetsova AV; Popova OP; Astakhov DA; Ivanov YV; Panchenkov DN; Ivanov AA
    Arkh Patol; 2022; 84(5):65-70. PubMed ID: 36178225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of stromal cancer-associated fibroblasts in pancreatic cancer.
    von Ahrens D; Bhagat TD; Nagrath D; Maitra A; Verma A
    J Hematol Oncol; 2017 Mar; 10(1):76. PubMed ID: 28351381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.